CHGA and neuroendocrine neoplasm: Notably, the expression of genes found to be typically active in neuroendocrine tumors (Hofsli gene signature [15]) were also significantly diminished in 424GC cells, including genes encoding neuroendocrine markers such as chromogranin A, dopa decarboxylase (DDC) and TPH1.